The serotonin-estrogen axis describes the bidirectional relationship between estrogen signaling and serotonin (5-HT) neurotransmission—a neuroendocrine interface that is profoundly modulated by the Gut Microbiome. Estrogen regulates serotonin synthesis (via tryptophan hydroxylase expression), serotonin receptor density (5-HT2A), and serotonin reuptake transporter (SERT) expression.
Conversely, serotonin modulates hypothalamic GnRH pulsatility, affecting estrogen production. The gut microbiome sits at the center of both systems: it controls estrogen recirculation (Estrobolome) and produces ~95% of the body's serotonin via enterochromaffin cell stimulation.
Evidence map3 cited passagesInspect provenance +
Estrobolome → estrogen levels: Gut bacterial beta glucuronidase deconjugates estrogens, increasing circulating free estrogen. dysbiosis alters the estrobolome, disrupting estrogen homeostasis.
PMDD: Abnormal serotonergic sensitivity to estrogen/progesterone fluctuations across the menstrual cycle. The interaction between allopregnanolone (GABA-A modulator), estrogen, and serotonin defines PMDD neurobiology.
Postpartum depression: Precipitous estrogen drop at delivery disrupts the serotonin-estrogen equilibrium. Inflammatory biomarkers (IL-6, TNF-alpha) compound the disruption.
The Microbiome Connection#
Three microbiome pathways converge on this axis:
- Estrobolome → estrogen levels: Gut bacterial Beta-Glucuronidase deconjugates estrogens, increasing circulating free estrogen. Dysbiosis alters the estrobolome, disrupting estrogen homeostasis.[1]Kaliannan et al. 2018 — Estrogen-Mediated Gut Microbiome Alterations Influence Sexual Dimorphism in Metabolic Syndrome in MiceKanakaraju Kaliannan, Ruairi C. Robertson, Kiera Murphy et al. · 2018Open reference 1 ↓
- Tryptophan metabolism → serotonin: The microbiome modulates tryptophan availability for serotonin synthesis. Dysbiosis-driven Metal-Driven Inflammation shunts tryptophan into the Kynurenine Pathway (via IDO/TDO), reducing serotonin precursor availability.
- SCFA → enterochromaffin cells → 5-HT release: Short-chain fatty acids (particularly Butyrate) stimulate enterochromaffin cells to release serotonin. SCFA depletion from dysbiosis reduces peripheral serotonin production.
Clinical Relevance#
PMDD: Abnormal serotonergic sensitivity to estrogen/progesterone fluctuations across the menstrual cycle. The interaction between Allopregnanolone (GABA-A modulator), estrogen, and serotonin defines PMDD neurobiology.[2]Cheng 2025 — Neuroinflammation in PMS and PMDD (Review)Cheng et al. · 2025Open reference 2 ↓[3]Itriyeva 2022 — PMS and PMDD in Adolescents (Review)Khalida Itriyeva · 2022Open reference 3 ↓[4]Nexha 2024 — Biological Rhythms in PMS/PMDD (Systematic Review)Adile Nexha, Luisa Caropreso, Taiane de Azevedo Cardoso et al. · 2024Open reference 4 ↓
Postpartum depression: Precipitous estrogen drop at delivery disrupts the serotonin-estrogen equilibrium. Inflammatory biomarkers (IL-6, TNF-alpha) compound the disruption.[5]Silva-Fernandes 2024 — Inflammatory Biomarkers and Perinatal Depression: A Systematic ReviewAnabela Silva-Fernandes, Ana Conde, Margarida Marques et al. · 2024Open reference 5 ↓
Menopausal depression: Estrogen decline reduces serotonergic tone → increased depression risk. Endometriosis: Estrogen excess (via dysbiotic estrobolome) drives lesion growth while serotonergic disruption drives associated pain and mood symptoms.
Cross-References#
- Serotonin—neurotransmitter page
- Estrobolome—microbial estrogen recirculation (Primitive 7)
- Allopregnanolone—GABA-A modulator in the estrogen-progesterone-serotonin triad
- GABA (Gamma-Aminobutyric Acid)—complementary inhibitory neurotransmitter
- Gut-Brain Axis—broader gut-brain framework
- Tryptophan—serotonin precursor
- Kynurenine Pathway—inflammation-driven tryptophan shunting away from serotonin
- Beta-Glucuronidase—estrogen deconjugation enzyme
References 5
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Kanakaraju Kaliannan, Ruairi C. Robertson, Kiera Murphy et al. (2018). Kaliannan et al. 2018 — Estrogen-Mediated Gut Microbiome Alterations Influence Sexual Dimorphism in Metabolic Syndrome in Mice. Microbiome.
- 2
Cheng et al. (2025). Cheng 2025 — Neuroinflammation in PMS and PMDD (Review). Frontiers in Endocrinology.
- 3
Khalida Itriyeva (2022). Itriyeva 2022 — PMS and PMDD in Adolescents (Review). Current Problems in Pediatric and Adolescent Health Care.
- 4
Adile Nexha, Luisa Caropreso, Taiane de Azevedo Cardoso et al. (2024). Nexha 2024 — Biological Rhythms in PMS/PMDD (Systematic Review). BMC Women's Health.
- 5
Anabela Silva-Fernandes, Ana Conde, Margarida Marques et al. (2024). Silva-Fernandes 2024 — Inflammatory Biomarkers and Perinatal Depression: A Systematic Review. PLOS ONE.
Article network
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Published page changes
This record shows only material changes published on this page, including changes to its content, evidence, conclusions, or author context. Internal processes and discussion activity are excluded. Pending, declined, and withdrawn proposals remain private.
- published revision
Revised “The Microbiome Connection”: now reads “deconjugates estrogens, increasing circulating free estrogen. dysbiosis alters the estrobolome, disrupting estrogen homeostasis.”.
Revised “The Microbiome Connection”: changed “deconjugates estrogens, increasing circulating free estrogen. Dysbiosis alters the estrobolome, disrupting estrogen homeostasis.” to “deconjugates estrogens, increasing circulating free estrogen. dysbiosis alters the estrobolome, disrupting estrogen homeostasis.”. · Karen Pendergrass · +1 −1
Inspect exact Git diff ↗ - published revision
Created “Serotonin-Estrogen Axis”: The serotonin-estrogen axis describes the bidirectional relationship between estrogen signaling and serotonin (5-HT) neurotransmission — a neuroendocrine interface that is profoundly modulated by the…
Created “Serotonin-Estrogen Axis”: The serotonin-estrogen axis describes the bidirectional relationship between estrogen signaling and serotonin (5-HT) neurotransmission — a neuroendocrine interface that is profoundly modulated by the… Published sections: Overview; The Microbiome Connection; Clinical Relevance; Cross-References. · WikiBiome Deploy Bot · +52 −0
Inspect exact Git diff ↗
